Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
PTC Inc ha un obiettivo di prezzo di consenso pari a $203.63, stabilito in base alle ultime valutazioni degli analisti di 16. Le ultime 3 valutazioni degli analisti sono state rilasciate da Barclays, RBC Capital y Stifel il julio 31, 2025. Con un obiettivo di prezzo medio di $229.33 tra le Barclays, RBC Capital y Stifel, c'è un implicito 9.41% upside per PTC Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Barclays
RBC Capital
Stifel
Piper Sandler
Keybanc
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para PTC
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
07/31/2025 | 11.16% | Barclays | $203 → $233 | Maintains | Overweight | |||
07/31/2025 | 12.12% | RBC Capital | $224 → $235 | Maintains | Outperform | |||
07/31/2025 | 4.96% | Stifel | $200 → $220 | Maintains | Buy | |||
07/31/2025 | -4.58% | Piper Sandler | $180 → $200 | Maintains | Neutral | |||
07/31/2025 | 16.89% | Keybanc | $192 → $245 | Maintains | Overweight | |||
07/31/2025 | 14.5% | Oppenheimer | $225 → $240 | Maintains | Outperform | |||
07/31/2025 | 8.3% | Rosenblatt | $204 → $227 | Maintains | Buy | |||
07/29/2025 | -2.67% | Rosenblatt | $204 → $204 | Maintains | Buy | |||
07/25/2025 | 7.35% | Oppenheimer | $210 → $225 | Maintains | Outperform | |||
07/16/2025 | 0.19% | Oppenheimer | $190 → $210 | Maintains | Outperform | |||
07/14/2025 | -3.15% | Barclays | $175 → $203 | Maintains | Overweight | |||
07/07/2025 | -8.4% | Keybanc | $185 → $192 | Maintains | Overweight | |||
06/12/2025 | -9.35% | Oppenheimer | $170 → $190 | Maintains | Outperform | |||
05/01/2025 | -4.58% | Stifel | $230 → $200 | Maintains | Buy | |||
05/01/2025 | -8.87% | Baird | $185 → $191 | Maintains | Outperform | |||
05/01/2025 | -2.67% | Rosenblatt | $204 → $204 | Maintains | Buy | |||
05/01/2025 | -14.12% | Piper Sandler | $202 → $180 | Maintains | Neutral | |||
04/25/2025 | -18.89% | Oppenheimer | $210 → $170 | Maintains | Outperform | |||
04/22/2025 | -11.74% | Baird | $181 → $185 | Maintains | Outperform | |||
04/16/2025 | -11.74% | Keybanc | $211 → $185 | Maintains | Overweight | |||
04/15/2025 | -23.66% | Mizuho | $190 → $160 | Maintains | Neutral | |||
04/14/2025 | -16.51% | Barclays | $215 → $175 | Maintains | Overweight | |||
04/09/2025 | -23.66% | JP Morgan | $210 → $160 | Downgrade | Overweight → Neutral | |||
02/06/2025 | 0.67% | Keybanc | $205 → $211 | Maintains | Overweight | |||
02/06/2025 | -2.67% | Rosenblatt | $204 → $204 | Maintains | Buy | |||
02/05/2025 | -6.97% | Citigroup | $200 → $195 | Maintains | Neutral | |||
02/04/2025 | -2.67% | Rosenblatt | $204 → $204 | Maintains | Buy | |||
12/18/2024 | 9.73% | Stifel | $200 → $230 | Maintains | Buy | |||
12/02/2024 | 0.19% | JP Morgan | $200 → $210 | Maintains | Overweight | |||
11/07/2024 | 8.78% | Baird | $226 → $228 | Maintains | Outperform | |||
11/07/2024 | 9.73% | RBC Capital | $202 → $230 | Maintains | Outperform | |||
11/07/2024 | -3.63% | Piper Sandler | $182 → $202 | Maintains | Neutral | |||
10/22/2024 | 7.82% | Baird | $216 → $226 | Maintains | Outperform | |||
10/10/2024 | -6.97% | Rosenblatt | $195 → $195 | Maintains | Buy | |||
08/01/2024 | -1.72% | BMO Capital | $200 → $206 | Maintains | Outperform | |||
08/01/2024 | -3.63% | RBC Capital | $202 → $202 | Reiterates | Outperform → Outperform | |||
08/01/2024 | -13.17% | Piper Sandler | $177 → $182 | Maintains | Neutral | |||
08/01/2024 | -6.97% | Rosenblatt | $190 → $195 | Maintains | Buy | |||
06/04/2024 | -9.35% | Mizuho | $200 → $190 | Downgrade | Buy → Neutral | |||
05/02/2024 | -10.78% | Citigroup | $195 → $187 | Maintains | Neutral | |||
05/02/2024 | -4.58% | Mizuho | $210 → $200 | Maintains | Buy | |||
05/02/2024 | 3.05% | Baird | $210 → $216 | Maintains | Outperform | |||
04/12/2024 | -6.97% | Rosenblatt | $195 → $195 | Maintains | Buy | |||
04/11/2024 | 2.58% | Barclays | $198 → $215 | Maintains | Overweight | |||
04/02/2024 | 0.19% | Baird | → $210 | Maintains | Outperform | |||
02/01/2024 | -3.63% | RBC Capital | $202 → $202 | Reiterates | Outperform → Outperform | |||
02/01/2024 | -6.97% | Rosenblatt | $166 → $195 | Maintains | Buy | |||
02/01/2024 | -4.58% | BMO Capital | $195 → $200 | Maintains | Outperform | |||
02/01/2024 | -2.19% | Keybanc | $190 → $205 | Maintains | Overweight | |||
02/01/2024 | 0.19% | Oppenheimer | $190 → $210 | Maintains | Outperform | |||
02/01/2024 | 0.19% | Mizuho | $200 → $210 | Maintains | Buy | |||
01/23/2024 | -6.97% | BMO Capital | $184 → $195 | Maintains | Outperform | |||
01/19/2024 | -2.19% | Baird | $200 → $205 | Maintains | Outperform | |||
01/12/2024 | -9.35% | Keybanc | $177 → $190 | Maintains | Overweight | |||
01/09/2024 | -15.55% | Piper Sandler | $155 → $177 | Maintains | Neutral | |||
01/04/2024 | -4.58% | JP Morgan | $130 → $200 | Upgrade | Neutral → Overweight | |||
12/11/2023 | -9.35% | Oppenheimer | $165 → $190 | Maintains | Outperform | |||
11/02/2023 | -26.05% | Piper Sandler | $150 → $155 | Reiterates | Neutral → Neutral | |||
10/30/2023 | -21.28% | Oppenheimer | → $165 | Upgrade | Perform → Outperform | |||
07/28/2023 | -14.12% | Mizuho | $170 → $180 | Maintains | Buy | |||
07/27/2023 | -16.51% | RBC Capital | $165 → $175 | Maintains | Outperform | |||
07/27/2023 | -20.8% | Barclays | $163 → $166 | Maintains | Overweight | |||
07/27/2023 | -28.44% | Piper Sandler | → $150 | Reiterates | Neutral → Neutral | |||
07/27/2023 | -15.55% | Keybanc | $160 → $177 | Maintains | Overweight | |||
07/25/2023 | -29.39% | Rosenblatt | → $148 | Reiterates | Buy → Buy | |||
07/24/2023 | -21.28% | RBC Capital | $158 → $165 | Maintains | Outperform | |||
07/14/2023 | -22.23% | Barclays | $152 → $163 | Maintains | Overweight | |||
06/21/2023 | -27.96% | Stifel | → $151 | Reiterates | Buy → Buy | |||
06/14/2023 | -28.44% | Piper Sandler | → $150 | Initiates | → Neutral | |||
05/24/2023 | -20.8% | BMO Capital | → $166 | Initiates | → Outperform | |||
05/17/2023 | -18.89% | Mizuho | $165 → $170 | Maintains | Buy | |||
05/17/2023 | -24.62% | RBC Capital | → $158 | Reiterates | Outperform → Outperform | |||
05/17/2023 | -29.39% | Rosenblatt | → $148 | Reiterates | Buy → Buy | |||
04/27/2023 | -24.62% | RBC Capital | $155 → $158 | Maintains | Outperform | |||
04/27/2023 | -27.48% | Barclays | $150 → $152 | Maintains | Overweight | |||
04/24/2023 | -33.21% | Citigroup | $147 → $140 | Maintains | Neutral | |||
04/14/2023 | -29.39% | Rosenblatt | → $148 | Reiterates | → Buy | |||
02/02/2023 | -18.89% | Loop Capital | $160 → $170 | Maintains | Buy | |||
02/02/2023 | -37.98% | JP Morgan | $128 → $130 | Maintains | Neutral | |||
02/02/2023 | -21.28% | Mizuho | $155 → $165 | Maintains | Buy | |||
02/02/2023 | -28.44% | Barclays | $144 → $150 | Maintains | Overweight | |||
02/02/2023 | -29.39% | Rosenblatt | $142 → $148 | Maintains | Buy | |||
02/02/2023 | -23.66% | Keybanc | $155 → $160 | Maintains | Overweight | |||
01/30/2023 | -26.05% | RBC Capital | $140 → $155 | Maintains | Outperform | |||
01/27/2023 | -29.87% | Citigroup | $135 → $147 | Maintains | Neutral | |||
01/26/2023 | -21.28% | Baird | $150 → $165 | Maintains | Outperform | |||
01/23/2023 | -26.05% | Keybanc | → $155 | Upgrade | Sector Weight → Overweight | |||
01/11/2023 | -31.3% | Barclays | $148 → $144 | Maintains | Overweight | |||
01/11/2023 | -26.05% | Berenberg | → $155 | Initiates | → Buy | |||
01/05/2023 | -32.25% | Rosenblatt | $138 → $142 | Maintains | Buy | |||
11/18/2022 | -26.05% | Mizuho | $135 → $155 | Maintains | Buy | |||
11/17/2022 | -29.39% | Barclays | $135 → $148 | Maintains | Overweight | |||
11/03/2022 | -33.21% | RBC Capital | $135 → $140 | Maintains | Outperform | |||
11/03/2022 | -34.16% | Rosenblatt | $146 → $138 | Maintains | Buy | |||
10/24/2022 | -31.3% | Baird | $153 → $144 | Maintains | Outperform | |||
09/19/2022 | -38.93% | JP Morgan | → $128 | Reinstates | → Neutral |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de PTC (PTC)?
El último precio objetivo de PTC (NASDAQ:PTC) fue comunicado por Barclays el julio 31, 2025. La firma de analistas fijó un precio objetivo para $233.00 que espera PTC a rise dentro de 12 meses (un posible 11.16% upside). 34 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre PTC (PTC)?
La última calificación de analistas para PTC (NASDAQ:PTC) fue proporcionada por Barclays, y PTC mantuvo su overweight calificación.
¿Cuándo se produjo la última revisión al alza de PTC (PTC)?
La última revisión al alza de PTC Inc se produjo en enero 4, 2024, cuando JP Morgan elevó su precio objetivo a $200. JP Morgan anteriormente tenía a neutral para PTC Inc.
¿Cuándo fue la última revisión a la baja de PTC (PTC)?
La última revisión a la baja de PTC Inc se produjo en abril 9, 2025, cuando JP Morgan cambió su precio objetivo de $210 a $160 para PTC Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para PTC (PTC)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de PTC, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de PTC se registró el julio 31, 2025, por lo que la próxima calificación estará disponible en torno al julio 31, 2026.
¿Es correcta la calificación de los analistas sobre PTC (PTC)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de PTC (PTC) fue un mantuvo con un precio objetivo de $203.00 a $233.00. El precio actual al que cotiza PTC (PTC) es de $209.60, que es within del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.